Category - News

Developments

Lexicon signs exclusive licencing agreement with Viatris for sotagliflozin outside U.S. and Europe

Lexicon Pharmaceuticals (NASDAQ:LXRX) has announced that Viatris (NASDAQ:VTRS) obtained an exclusive license from Lexicon to commercialize sotagliflozin across all indications outside the U.S. and Europe, in exchange...

October 17, 2024

Markets

Capricor prices common stock offering

Capricor Therapeutics (NASDAQ:CAPR) has priced a public offering of 4,412,000 common shares at a price of $17.00 per share. Capricor also granted underwriters a 30-day option to purchase up to an additional 661,800...

October 17, 2024

Developments

Celularity expands portfolio acquiring Rebound from Sequence

Celularity (NASDAQ:CELU) has announced its acquisition of Rebound from Sequence LifeScience, expanding its commercial portfolio of placental-derived advanced biomaterial products. Rebound is a full thickness placental...

October 17, 2024

Executive Moves

Tom Tamberrino joins Profound as new CCO ahead of TULSA reimbursement going into effect at the start of 2025

Profound Medical (NASDAQ:PROF; TSX:PRN) announced the appointment of Tom Tamberrino as chief commercial officer (CCO). Abbey Goodman, the current CCO, will now lead strategic partnerships and continue to report to CEO...

October 17, 2024

Developments

Corbus reports enrollment completion of dose escalation stage of Phase 1 trial

Corbus Pharmaceuticals (NASDAQ:CRBP) has announced the completion of enrollment for the dose-escalation portion of its bridging Phase 1 clinical trial of CRB-701 (SYS6002) in patients with advanced solid tumors...

October 16, 2024

Developments

EC grants orphan medicinal product designation of Theriva’s VCN-01 for retinoblastoma

Theriva Biologics (NYSE American:TOVX) has announced that the European Commission (EC) has adopted the European Medicines Agency’s (EMA) recommendation to grant orphan medicinal product designation to its lead...

October 16, 2024

Executive Moves

Lake Street Captial Markets names Alex Nowak as director investment banking

Alex Nowak has joined Lake Street Capital Markets’ growing banking team as director of the healthcare investment banking practice. In his new role, Mr. Nowak will focus on expanding client relationships and supporting...

October 15, 2024

Executive Moves

Murat Omur joins Ladenburg Thalmann as managing director in healthcare IB

Ladenburg Thalmann has announced the appointment of Murat Omur as managing director in the healthcare investment banking division. With 17 years of investment banking experience in healthcare and the M&A sector, Mr...

October 15, 2024

Developments

Ripple and Glaukos ink evaluation and licensing agreements

Closely-held Ripple Therapeutics has announced evaluation and licensing agreements with Glaukos Corporation (NYSE:GKOS), enabling Glaukos to leverage Ripple’s proprietary technology platform to create sustained release...

October 15, 2024

Developments

Aurinia presents new real-world data reinforcing LUPKYNIS in LN at ASN Kidney Week 2024

Aurinia Pharmaceuticals (NASDAQ:AUPH) has announced plans to present new data reinforcing the clinical significance of LUPKYNIS in the treatment of lupus nephritis (LN) at the American Society of Nephrology (ASN) Kidney...

October 11, 2024

Category - News

Subscribe